Tonix Pharmaceuticals

About:

Tonix Pharmaceuticals develops pharmaceutical products for central nervous system disorders.

Website: http://www.tonixpharma.com

Twitter/X: TONIXPharma

Top Investors: Deerfield, Technology Partners, Broadfin Capital, Sabby Management

Description:

Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring, and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is primarily composed of the central nervous system (CNS) and immunology product candidates. The CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions.

Total Funding Amount:

$317M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

New York, New York, United States

Founded Date:

2007-11-16

Contact Email:

jobs(AT)tonixpharma.com

Founders:

Seth Lederman

Number of Employees:

11-50

Last Funding Date:

2024-06-12

IPO Status:

Public

© 2025 bioDAO.ai